Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advance in basic and clinical research of Xuezhikang Capsule.

× No keyword cloud information.

9 in total

1. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.

Authors: Jian-Jun Li; Sheng-Shou Hu; Chun-Hong Fang; Rui-Tai Hui; Li-Fu Miao; Yue-Jin Yang; Run-Lin Gao
Journal: Clin Chim Acta Date: 2005-02 Impact factor: 3.786

2. [China coronary secondary prevention study (CCSPS)].

Authors: Zong-Liang Lu
Journal: Zhonghua Xin Xue Guan Bing Za Zhi Date: 2005-02

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors: F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245

4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors:
Journal: Lancet Date: 1994-11-19 Impact factor: 79.321

5. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease.

Authors: Shui Ping Zhao; Ling Liu; Yan Chun Cheng; Mehdi H Shishehbor; Ming Hui Liu; Dao Quan Peng; Yu Ling Li
Journal: Circulation Date: 2004-08-16 Impact factor: 29.690

6. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors:
Journal: N Engl J Med Date: 1998-11-05 Impact factor: 91.245

7. Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease.

Authors: Ling Liu; Shui-Ping Zhao; Yan-Chun Cheng; Yu-Ling Li
Journal: Clin Chem Date: 2003-08 Impact factor: 8.327

8. [Effect of xuezhikang on blood lipids, serum oxidized low density lipoprotein, C-reactive protein and fibrinogen in patients with unstable angina pectoris].

Authors: Qing-hai Yao; Chang-cong Cui; Jun-kui Wang
Journal: Zhongguo Zhong Xi Yi Jie He Za Zhi Date: 2003-10

9. Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease.

Authors: Shui-Ping Zhao; Ling Liu; Yan-Chun Cheng; Yu-Ling Li
Journal: Atherosclerosis Date: 2003-06 Impact factor: 5.162

9 in total

3 in total

1. Red yeast rice repairs kidney damage and reduces inflammatory transcription factors in rat models of hyperlipidemia.

Authors: Mei Ding; Daoyuan Si; Wenqi Zhang; Zhaohui Feng; Min He; Ping Yang
Journal: Exp Ther Med Date: 2014-10-21 Impact factor: 2.447

2. A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia.

Authors: Qinghua Shang; Zhaolan Liu; Keji Chen; Hao Xu; Jianping Liu
Journal: Evid Based Complement Alternat Med Date: 2012-04-12 Impact factor: 2.629

3. The effect of adropin on lipid and glucose metabolism in rats with hyperlipidemia.

Authors: Raziye Akcılar; Fatma Emel Koçak; Hasan Şimşek; Aydın Akcılar; Zeynep Bayat; Ezgi Ece; Hülya Kökdaşgil
Journal: Iran J Basic Med Sci Date: 2016-03 Impact factor: 2.699

3 in total